热门出版物 - 学术资源搜索

h5 指数:23
h5 中位数:28

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#17 Transplantation

标题/作者	引用次数	年份
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study R Ram, D Hagin, N Kikozashvilli, T Freund, O Amit, Y Bar-On, ... Transplantation and Cellular Therapy 27 (9), 788-794	127	2021
Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients H Ali, D Ngo, A Aribi, S Arslan, S Dadwal, G Marcucci, R Nakamura, ... Transplantation and Cellular Therapy 27 (11), 938. e1-938. e6	67	2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report CL Kitko, J Pidala, HM Schoemans, A Lawitschka, ME Flowers, ... Transplantation and Cellular Therapy 27 (7), 545-557	60	2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report D Wolff, V Radojcic, R Lafyatis, R Cinar, RK Rosenstein, EW Cowen, ... Transplantation and Cellular Therapy 27 (10), 817-835	50	2021
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy MA Kharfan-Dabaja, A Kumar, E Ayala, M Aljurf, T Nishihori, R Marsh, ... Transplantation and Cellular Therapy 27 (8), 642-649	47	2021
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes—Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial BL Scott, MC Pasquini, M Fei, R Fraser, J Wu, SM Devine, DL Porter, ... Transplantation and Cellular Therapy 27 (6), 483. e1-483. e6	40	2021
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy B Dholaria, BN Savani, BK Hamilton, B Oran, HD Liu, MS Tallman, ... Transplantation and Cellular Therapy 27 (1), 6-20	38	2021
Chimeric Antigen Receptor T Cell Therapy: A Comprehensive Review of Clinical Efficacy, Toxicity, and Best Practices for Outpatient Administration M Alexander, K Culos, J Roddy, JR Shaw, C Bachmeier, TL Shigle, ... Transplantation and Cellular Therapy 27 (7), 558-570	36	2021
Enteral versus Parenteral Nutrition as Nutritional Support after Allogeneic Hematopoietic Stem Cell Transplantation: a Systematic Review and Meta-Analysis D Zama, D Gori, E Muratore, D Leardini, F Rallo, S Turroni, A Prete, ... Transplantation and Cellular Therapy 27 (2), 180. e1-180. e8	32	2021
Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States CA Jacobson, FL Locke, L Ma, J Asubonteng, ZH Hu, T Siddiqi, S Ahmed, ... Transplantation and Cellular Therapy 28 (9), 581. e1-581. e8	31	2022
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients MU Mushtaq, M Shahzad, SG Chaudhary, M Luder, N Ahmed, ... Transplantation and Cellular Therapy 27 (9), 796. e1-796. e7	30	2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report Z DeFilipp, DR Couriel, A Lazaryan, VR Bhatt, NP Buxbaum, AM Alousi, ... Transplantation and Cellular Therapy 27 (9), 729-737	28	2021
Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Leukemia Remission Confers a Leukemia-Free Survival Advantage C Summers, QV Wu, C Annesley, M Bleakley, A Dahlberg, ... Transplantation and Cellular Therapy 28 (1), 21-29	27	2022
Posttransplantation Cyclophosphamide-and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant R Greco, F Lorentino, S Albanese, MTL Stanghellini, F Giglio, ... Transplantation and Cellular Therapy 27 (9), 776. e1-776. e13	27	2021
Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213) C Cutler, SJ Lee, S Arai, M Rotta, B Zoghi, A Ramakrishnan, A Lazaryan, ... Transplantation and Cellular Therapy, Official Publication of the American …	27	2021
MSC-Derived Extracellular Vesicles to Heal Diabetic Wounds: A Systematic Review and Meta-Analysis of Preclinical Animal Studies A Bailey, H Li, A Kirkham, A Tieu, H Maganti, R Shorr, D Fergusson, ... Transplantation and Cellular Therapy, Official Publication of the American …	27	2021
Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients S Easdale, R Shea, L Ellis, J Bazin, K Davis, F Dallas, E Thistlethwayte, ... Transplantation and Cellular Therapy 27 (10), 880. e1-880. e4	27	2021
State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses J Meir, MA Abid, MB Abid Transplantation and Cellular Therapy 27 (12), 973-987	26	2021
Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis A Lin, J Flynn, L DeRespiris, B Figgins, M Griffin, C Lau, A Proli, ... Transplantation and Cellular Therapy 27 (1), 85. e1-85. e6	25	2021
Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis AS Kittai, Y Huang, M Gordon, N Denlinger, A Mian, L Fitzgerald, J Bishop, ... Transplantation and Cellular Therapy 27 (1), 46-52	25	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。